BIOCONNSEBiocon Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 15 Jun · 19:12 IST

Promoter Kiran Mazumdar-Shaw declares no encumbrance on Biocon shares for FY26

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.1%1-day move
₹416.00
prior close
₹418.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.1-0.2+0.1-1.1-0.4-0.1+0.8+1.8+0.0-4.4+6.3
Up moveDown movePending
AI summary

Kiran Mazumdar-Shaw, on behalf of Biocon's Promoter and Promoter Group, has filed a declaration under SEBI SAST Regulation 31(4) confirming that no encumbrance — such as pledge, lien, or charge — was created on their shares in the company during the financial year ending March 31, 2026. This is a routine annual compliance filing required from promoters to disclose any encumbrances on their holdings.

Likely market impact

Positive signal — promoters have not pledged any Biocon shares in FY26, suggesting no financial stress on promoter holdings.